PXD064291
PXD064291 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | GLP-1RA Ameliorates Polycystic Ovary Syndrome via Hypothalamic RASA1/AKT: A Novel pathway Linking Hyperandrogenism to GnRH Dysregulation |
| Description | Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenemia and hypothalamic-pituitary-gonadal (HPG) axis dysregulation involving gonadotropin-releasing hormone (GnRH) hyperactivity. While glucagon-like peptide-1 receptor agonists (GLP-1RAs) show therapeutic promise in PCOS, their central regulation mechanisms remain unknown. Here, we demonstrate that GLP-1RA improves follicular maturation in PCOS via hypothalamic RASA1-dependent modulation of GnRH secretion. Based on our letrozole-induced PCOS rats, GLP-1RA was shown to restore hormonal homeostasis by normalizing testosterone, suppressing luteinizing hormone, and reinstating estrous cyclicity alongside ovarian recovery. Proteomics analysis revealed a substantial recovery from hyperandrogenism-induced hypothalamic dysregulation after GLP-1RA therapy. Landscapes of PCOS and GLP-1RA hypothalamic perturbations were systematically drawn. Crucially, subsequent network analysis identified RASA1-GnRH axis as a core axis underpins GLP-1RA related pharmacological rescue of PCOS hypothalamus. Bidirectional genetic perturbations of RASA1 in GnRH neurons rigorously confirmed RASA1's regulation over GnRH synthesis, as well as the mediating role of Ras/AKT in this pathway. Notably, the modulation of both RASA1 and Akt effectively counteracted testosterone-induced GnRH hypersecretion and reversed GLP-1RA treatment-mediated GnRH suppression, thereby fully establishing GLP-1RA’s pharmacological mechanism through RASA1-Ras/Akt-GnRH signaling axis. Our study represented the first investigation into the hypothalamic molecular mechanism by which GLP-1RA improves PCOS, highlighting RASA1 as a critical mediator of HPG axis in the female reproductive systems. The discovery of novel target in central control would serve as a promising therapeutic strategy for PCOS reproductive improvement beyond metabolic treatment. |
| HostingRepository | iProX |
| AnnounceDate | 2025-05-26 |
| AnnouncementXML | Submission_2025-05-26_19:50:45.287.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Linlin Yang |
| SpeciesList | scientific name: Rattus norvegicus; NCBI TaxID: 10116; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | Q Exactive HF-X |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2025-05-26 01:16:26 | ID requested | |
| ⏵ 1 | 2025-05-26 19:50:45 | announced |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: GLP-1RA, GnRH, Hypothalamus, RASA1, PCOS |
Contact List
| Linlin Yang | |
|---|---|
| contact affiliation | Hebei Medical University |
| contact email | llyang@hebmu.edu.cn |
| lab head | |
| Linlin Yang | |
| contact affiliation | The first hospital of Hebei Medical University |
| contact email | llyang@hebmu.edu.cn |
| dataset submitter | |
Full Dataset Link List
| iProX dataset URI |




